Life Bio is ready for world’s first partial epigenetic reprogramming trials... expected later this year.
Building a longevity clinic as a clinical study
Colossal's woolly mouse project represents significant progress, not just for de-extinction but also potentially for human health and longevity.
Startup emerges with nanoparticle-based brain-computer interface
Clock.bio decodes rejuvenation biology across the human genome
Open-source medtech company Openwater is using light and sound to diagnose and treat diseases at a cellular level.
XPRIZE Healthspan launches: $101m prize for team that develops successful longevity therapeutic.
News: A new clinical trial is underway across the United States, seeking to assess the effects of rapamycin on health and aging in dogs.
Does rapamycin extend lifespan in dogs?
Are there any stats on global longevity-related R&D funding over the last 10 years?
Clock.bio launches to decode rejuvenation biology across human genome
Eterna is harnessing the potential of mRNA engineering in cellular reprogramming, gene therapy and longevity.
Telocyte’s gene therapy is funded through to clinical trials.
New Cambrian company: Isterian Biotech will focus on developing novel drugs to stop and reverse the pathological accumulation of crosslinked proteins commonly observed in all major organs with age.
Immunicom founder on how blood filtering device for cancer treatment could be applied in age-related disease and longevity.
Sir John Bell: ‘No health system in the world is currently sustainable’
Sir John Bell on the need for a prevention-based approach to healthcare: ‘No health system in the world is currently sustainable’
‘No evidence’ that centrophenoxine provides antiaging benefits
George Church on fast-tracking longevity therapies.
Nir Barzilai announces new longevity genetics study of 10,000 centenarians, with funding from crypto investor James Fickel.
Kitalys Institute founder on breaking down the barriers to longevity clinical trials
An antiaging supplement that also reduces appetite?
